Health & WellnessTech
Engineurix Corporation
Intellihat provides patented wearable technology for the aging brain. It is intended to reduce age-related cognitive decline.
Boston,
MA
Investment type:
Equity
(Common Stock)
Target raise:
$10,000
- $2,000,000
Minimum investment:
$99
$99
End date:
Feb 15, 2022
Feb 15, 2022
ended
Share
Intellihat® is a mass-market, consumer health device, in the form of a wearable hat, designed to slow the effects of cognitive decline due to natural aging. Intellihat aims to ride the new wave of wearable technology.Cognitive decline is the natural process where our mental abilities such as memory, visual attention, and reasoning decline with age.Intellihat was founded by two pioneers in the field of neuromodulation, Jeffrey E. Arle, MD, PhD and Jay L. Shils, PhD. Theyve authored over 150 research papers and are the editors of, as well as contributing authors to the leading texts, Essential Neuromodulation, Innovative Neuromodulation, and The Neuromodulation Casebook. 
Our Story
Watching those you care about develop health conditions that bring upon cognitive impairment/decline is devastating; especially since the pharmaceutical options and disease-modifying therapies developed to date have limited efficacy. Cognitive decline can begin as early as age 30, with many people noticing significant symptoms once they turn 50 years old.We believe the market for Intellihat is extraordinary - those aged 50 and over - and their loved ones and friends who want to give them a cool device to lessen cognitive decline.In a 2015-2017 subjective cognitive decline (SCD) study conducted by the CDC on adults aged 45 and above in the U.S.
Our Ambition
Our patented (#8,909,344) head worn brain stimulation device uses transcranial electrical stimulation (TES) to gently stimulate the dorsolateral prefrontal cortex (DLPFC), near the forehead.